ATE48643T1 - Verfahren zur herstellung von glucagon oder dessen derivaten in einem transformierten hefestamm. - Google Patents
Verfahren zur herstellung von glucagon oder dessen derivaten in einem transformierten hefestamm.Info
- Publication number
- ATE48643T1 ATE48643T1 AT86300384T AT86300384T ATE48643T1 AT E48643 T1 ATE48643 T1 AT E48643T1 AT 86300384 T AT86300384 T AT 86300384T AT 86300384 T AT86300384 T AT 86300384T AT E48643 T1 ATE48643 T1 AT E48643T1
- Authority
- AT
- Austria
- Prior art keywords
- derivatives
- glucagon
- yeast strain
- production
- transformed yeast
- Prior art date
Links
- 102000051325 Glucagon Human genes 0.000 title abstract 4
- 108060003199 Glucagon Proteins 0.000 title abstract 4
- 240000004808 Saccharomyces cerevisiae Species 0.000 title abstract 4
- MASNOZXLGMXCHN-ZLPAWPGGSA-N glucagon Chemical compound C([C@@H](C(=O)N[C@H](C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O)C(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CO)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CO)NC(=O)[C@H](CC=1C=CC(O)=CC=1)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](NC(=O)[C@H](CC=1C=CC=CC=1)NC(=O)[C@@H](NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC=1NC=NC=1)[C@@H](C)O)[C@@H](C)O)C1=CC=CC=C1 MASNOZXLGMXCHN-ZLPAWPGGSA-N 0.000 title abstract 4
- 229960004666 glucagon Drugs 0.000 title abstract 4
- 239000012634 fragment Substances 0.000 abstract 2
- 108091028043 Nucleic acid sequence Proteins 0.000 abstract 1
- 108700005078 Synthetic Genes Proteins 0.000 abstract 1
- 238000012423 maintenance Methods 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 230000010076 replication Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/575—Hormones
- C07K14/605—Glucagons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/37—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi
- C07K14/39—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from fungi from yeasts
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
- C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S930/00—Peptide or protein sequence
- Y10S930/01—Peptide or protein sequence
- Y10S930/30—Signal or leader sequence
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Mycology (AREA)
- Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biophysics (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Medicinal Chemistry (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Wood Science & Technology (AREA)
- General Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Biomedical Technology (AREA)
- Microbiology (AREA)
- Endocrinology (AREA)
- Plant Pathology (AREA)
- Toxicology (AREA)
- Physics & Mathematics (AREA)
- Diabetes (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Emergency Medicine (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DK27885A DK27885A (da) | 1985-01-22 | 1985-01-22 | Fremstilling af peptider |
| EP86300384A EP0189998B1 (de) | 1985-01-22 | 1986-01-20 | Verfahren zur Herstellung von Glucagon oder dessen Derivaten in einem transformierten Hefestamm |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE48643T1 true ATE48643T1 (de) | 1989-12-15 |
Family
ID=8091749
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT86300384T ATE48643T1 (de) | 1985-01-22 | 1986-01-20 | Verfahren zur herstellung von glucagon oder dessen derivaten in einem transformierten hefestamm. |
Country Status (17)
| Country | Link |
|---|---|
| US (1) | US4826763A (de) |
| EP (1) | EP0189998B1 (de) |
| JP (2) | JPH0720435B2 (de) |
| AT (1) | ATE48643T1 (de) |
| AU (1) | AU587218B2 (de) |
| CA (1) | CA1294232C (de) |
| DE (1) | DE3667488D1 (de) |
| DK (1) | DK27885A (de) |
| ES (1) | ES8708250A1 (de) |
| FI (1) | FI87800C (de) |
| GR (1) | GR860149B (de) |
| IE (1) | IE58726B1 (de) |
| MX (1) | MX163776B (de) |
| NO (1) | NO172185C (de) |
| NZ (1) | NZ214883A (de) |
| PT (1) | PT81872B (de) |
| ZA (1) | ZA86393B (de) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5151354A (en) * | 1986-08-21 | 1992-09-29 | Cornelius Hollenberg | Fermentation processes using amylolytic enzyme producing microorganisms |
| DE3751269T2 (de) * | 1986-09-19 | 1995-09-14 | Univ Washington | Expression des biologisch aktiven Faktors XIII. |
| JPH01187499A (ja) * | 1988-01-21 | 1989-07-26 | Science & Tech Agency | 原子炉解体用ロボット |
| IL93173A0 (en) * | 1989-02-01 | 1990-11-05 | Shionogi & Co | Production of glucagon |
| US6172039B1 (en) | 1990-04-16 | 2001-01-09 | Apex Bioscience, Inc. | Expression of recombinant hemoglobin and hemoglobin variants in yeast |
| US5234906A (en) * | 1991-01-10 | 1993-08-10 | Amylin Pharmaceuticals, Inc. | Hyperglycemic compositions |
| US5408037A (en) * | 1991-01-17 | 1995-04-18 | Zymogenetics, Inc. | Methods for detecting glucagon antagonists |
| US5510459A (en) * | 1991-01-17 | 1996-04-23 | Zymogenetics, Inc. | Glucagon antagonists |
| DE69302692T2 (de) * | 1992-07-06 | 1996-10-02 | Beckman Instruments Inc | Flüssigkeitsversorgungssystem mit Mehrwegventil |
| DK144093D0 (de) * | 1993-12-23 | 1993-12-23 | Novo Nordisk As | |
| US5652216A (en) * | 1994-05-26 | 1997-07-29 | Novo Nordisk A/S | Pharmaceutical preparation |
| WO1998052600A1 (en) * | 1997-05-16 | 1998-11-26 | 1149336 Ontario Inc. | Methods of enhancing functioning of the upper gastrointestinal tract |
| EP1578437A4 (de) * | 2002-12-27 | 2006-08-09 | Diobex Inc | Zusammensetzungen und verfahren zurvorbeugung und kontrolle der insulininduzierten hypoglykämie |
| US7655618B2 (en) * | 2002-12-27 | 2010-02-02 | Diobex, Inc. | Compositions and methods for the prevention and control of insulin-induced hypoglycemia |
| ES2610356T3 (es) | 2009-02-03 | 2017-04-27 | Amunix Operating Inc. | Polipéptidos recombinantes extendidos y composiciones que comprenden los mismos |
| PT2440228T (pt) | 2009-06-08 | 2018-12-24 | Amunix Operating Inc | Polipéptidos de regulação da glicose e métodos de preparação e utilização dos mesmos |
| WO2013130683A2 (en) | 2012-02-27 | 2013-09-06 | Amunix Operating Inc. | Xten conjugate compositions and methods of making same |
| ES2938734T3 (es) | 2018-10-09 | 2023-04-14 | Fresenius Kabi Ipsum S R L | Procedimiento para la fabricación de análogos de GLP-1 |
| EP3753946A1 (de) | 2019-06-18 | 2020-12-23 | Fresenius Kabi iPSUM S.r.l. | Verbessertes verfahren zur herstellung von hochreinem glucagon |
| CN114401981B (zh) | 2019-06-18 | 2024-11-08 | 北京费森尤斯卡比医药有限公司 | 胰高血糖素制造方法 |
| KR20220131221A (ko) | 2019-11-13 | 2022-09-27 | 아뮤닉스 파마슈티컬스, 인크. | 바코드화된 xten 폴리펩티드 및 이의 조성물, 및 이의 제조 방법 및 사용 방법 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4401759A (en) * | 1980-05-01 | 1983-08-30 | Harvey Rubin | Detection and isolation of glucagon mRNA using a synthetic oligodeoxynucleotide |
| DK283180A (da) * | 1980-07-01 | 1982-01-02 | Novo Industri As | Polypeptider og derivater deraf |
| US4546082A (en) * | 1982-06-17 | 1985-10-08 | Regents Of The Univ. Of California | E. coli/Saccharomyces cerevisiae plasmid cloning vector containing the alpha-factor gene for secretion and processing of hybrid proteins |
-
1985
- 1985-01-22 DK DK27885A patent/DK27885A/da unknown
-
1986
- 1986-01-20 NO NO860178A patent/NO172185C/no not_active IP Right Cessation
- 1986-01-20 JP JP61009822A patent/JPH0720435B2/ja not_active Expired - Lifetime
- 1986-01-20 IE IE16286A patent/IE58726B1/en not_active IP Right Cessation
- 1986-01-20 EP EP86300384A patent/EP0189998B1/de not_active Expired
- 1986-01-20 ES ES551042A patent/ES8708250A1/es not_active Expired
- 1986-01-20 MX MX1277A patent/MX163776B/es unknown
- 1986-01-20 ZA ZA86393A patent/ZA86393B/xx unknown
- 1986-01-20 PT PT81872A patent/PT81872B/pt active IP Right Revival
- 1986-01-20 FI FI860251A patent/FI87800C/fi not_active IP Right Cessation
- 1986-01-20 GR GR860149A patent/GR860149B/el active IP Right Revival
- 1986-01-20 AT AT86300384T patent/ATE48643T1/de not_active IP Right Cessation
- 1986-01-20 AU AU52472/86A patent/AU587218B2/en not_active Expired
- 1986-01-20 CA CA000499911A patent/CA1294232C/en not_active Expired - Lifetime
- 1986-01-20 DE DE8686300384T patent/DE3667488D1/de not_active Expired - Lifetime
- 1986-01-21 NZ NZ214883A patent/NZ214883A/en unknown
- 1986-01-21 US US06/820,144 patent/US4826763A/en not_active Expired - Lifetime
-
1993
- 1993-10-13 JP JP5255433A patent/JPH0746986B2/ja not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| IE860162L (en) | 1986-07-22 |
| JPH0746986B2 (ja) | 1995-05-24 |
| ES8708250A1 (es) | 1987-10-01 |
| JPH0720435B2 (ja) | 1995-03-08 |
| DK27885D0 (da) | 1985-01-22 |
| FI87800C (fi) | 1993-02-25 |
| NO172185C (no) | 1993-06-16 |
| PT81872B (pt) | 1988-05-27 |
| MX163776B (es) | 1992-06-22 |
| ES551042A0 (es) | 1987-10-01 |
| FI860251L (fi) | 1986-07-23 |
| AU587218B2 (en) | 1989-08-10 |
| EP0189998B1 (de) | 1989-12-13 |
| ZA86393B (en) | 1987-03-25 |
| NO860178L (no) | 1986-07-23 |
| PT81872A (en) | 1986-02-01 |
| US4826763A (en) | 1989-05-02 |
| NZ214883A (en) | 1988-04-29 |
| FI87800B (fi) | 1992-11-13 |
| DK27885A (da) | 1986-07-23 |
| JPH06292594A (ja) | 1994-10-21 |
| AU5247286A (en) | 1986-07-31 |
| CA1294232C (en) | 1992-01-14 |
| DE3667488D1 (de) | 1990-01-18 |
| GR860149B (en) | 1986-05-21 |
| NO172185B (no) | 1993-03-08 |
| JPS61181398A (ja) | 1986-08-14 |
| FI860251A0 (fi) | 1986-01-20 |
| EP0189998A1 (de) | 1986-08-06 |
| IE58726B1 (en) | 1993-11-03 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE48643T1 (de) | Verfahren zur herstellung von glucagon oder dessen derivaten in einem transformierten hefestamm. | |
| DE3856505D1 (de) | Proteine mit Faktor VIII Aktivität, Verfahren zu deren Herstellung unter Verwendung von genetisch modifizierten Zellen und diese enthaltende Zusammensetzungen | |
| AU2790292A (en) | Viral recombinant vectors for expression in muscle cells | |
| IT8167406A0 (it) | Procedimento e veicolo per la produzione di polipeptidi mediante espressione nei batteri di un codice genetico di struttura | |
| AU573768B2 (en) | Hyaluronic acid from streptococci | |
| DE3578435D1 (de) | Promotoren fuer die expression von fremden genen in hefe, plasmide, die diese promotoren enthalten, sowie deren verwendung zur herstellung von polypeptiden. | |
| DE3482812D1 (de) | Fraktionen von hyaluronsaeure mit pharmazeutischer aktivitaet, verfahren zu deren herstellung und sie enthaltende pharmazeutische zusammensetzungen. | |
| YU46597B (sh) | Postupak za proizvodnju hibridni interferoni humanih leukocita | |
| BG49717A3 (bg) | Метод за получаване на хирудин | |
| ATE78055T1 (de) | Verfahren zur herstellung von proteinen und transformierten zellen und dna-konstruktionen zur korrektur von mankos und wirtszellen sowie deren herstellung und verwendung. | |
| DE3888459D1 (de) | Zellzüchtung in kontinuierlicher Dispersionskultur mit einem System zur Gewinnung von Zellprodukten. | |
| EP0139878A3 (de) | Herstellung von Immun-Interferon und seiner m-RNS | |
| FI896261A7 (fi) | Menetelmä proteiinin tai polypeptidin valmistamiseksi, polypeptidiä ko odaava DNA-sekvenssi, DNA-sekvenssin sisältämä mikro-organismi sekä po lypeptidi ja sen käyttö farmaseuttisena valmisteena | |
| ES8303522A1 (es) | Procedimiento para la mutacion doble de virus del genero herpes | |
| AU3905893A (en) | Plant resistant to two or more viruses and preparation thereof | |
| ES2053766T3 (es) | Metodo para aumentar la expresion de un gen. | |
| EP0422217A4 (en) | Human recombinant placental ribonuclease inhibitor and method of production | |
| EP0343388A3 (de) | Expression von Gamma-Interferon in methylotrophischen Hefen | |
| ATE50453T1 (de) | Spezifisches polypeptid produzierende hybridzellinien, erhaeltlich aus primaerzellen, die spontan faehig sind zur expres sion dieses polypeptids oder eines aehnlichen polypeptids, verfahren zum erhalten dieser hybridzellen und deren verwendung zur herstellung dieses polypeptids. | |
| DE3853590D1 (de) | Rinder granulocyt-makrophagenkolonie stimulierender faktor. | |
| EP0369229A3 (de) | Verfahren zur Herstellung von Kunststoffen nach dem Polyisocyanatpolyadditionsverfahren sowie dafür geeignete Katalysatoren | |
| ATE104659T1 (de) | Verfahren zur herstellung von dmt-zwischenprodukt bestimmter reinheit sowie dessen weiterverarbeitung zu reinst-dmt und/oder mittel- oder hochreiner terephthalsaeure. | |
| DE3684560D1 (de) | Verwendung von ergolinderivaten zur herstellung eines arzneimittels zum schutz der nerven. | |
| ATE48985T1 (de) | Verfahren zur herstellung von organotonen mit gelbildungseigenschaften. |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| UEP | Publication of translation of european patent specification | ||
| EELA | Cancelled due to lapse of time |